Simplex Trading’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Simplex Trading’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40	Closed	-$1K	–	10768
2022 Q2	$1K	Buy	+40	New	+$1.14K	﹤0.01%	9658
2021 Q1	–	Sell	-1,096	Closed	-$56K	–	9872
2020 Q4	$56K	Buy	1,096 +535	+95%	+$25.5K	﹤0.01%	6057
2020 Q3	$23K	Sell	561 -98	-15%	-$4.04K	﹤0.01%	6273
2020 Q2	$27K	Buy	+659	New	+$26K	﹤0.01%	5996
2020 Q1	–	Sell	-339	Closed	-$14K	–	8171
2019 Q4	$14K	Buy	+339	New	+$12.6K	﹤0.01%	6203
2019 Q1	–	Sell	-692	Closed	-$19K	–	7755
2018 Q4	$19K	Buy	+692	New	+$22.9K	﹤0.01%	5379
2018 Q2	–	Sell	-820	Closed	-$28K	–	7828
2018 Q1	$28K	Buy	+820	New	+$28.7K	﹤0.01%	3022
2017 Q4	–	Sell	-66	Closed	-$2K	–	6583
2017 Q3	$2K	Sell	66 -38	-37%	-$1.11K	﹤0.01%	5149
2017 Q2	$2K	Sell	104 -100	-49%	-$2.6K	﹤0.01%	5331
2017 Q1	$5K	Buy	+204	New	+$5.08K	﹤0.01%	4620
2016 Q3	–	Sell	-602	Closed	-$13K	–	6375
2016 Q2	$13K	Buy	+602	New	+$14.3K	﹤0.01%	3344

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

ASB Consultores Aventura, Florida $30.1M AUM 22.96% 1-Year Est. Return

Simplex Trading's SBIO Position: Q3 2022 in Review

Simplex Trading sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2022, closing a stake of 40 shares — an estimated $1K sold.

Simplex Trading first reported a position in SBIO in Q2 2016 and held it in 11 quarters. The position peaked at $56K in Q4 2020. 44 funds tracked by Wall St. Rank hold SBIO as of Q3 2022.

Simplex Trading reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 40 ALPS Medical Breakthroughs ETF shares in Q3 2022, an estimated $1K.
Simplex Trading first reported a position in ALPS Medical Breakthroughs ETF in Q2 2016 and held it in 11 quarters.
Simplex Trading's ALPS Medical Breakthroughs ETF position peaked at $56K in Q4 2020.
44 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.